Per Vox: The Freedom Caucus laid their cards on the table in a meeting Thursday with the Washington Examiner’s editorial board. The group of conservative House members has narrowed their demands to two items:
- Ending Obamacare’s essential health benefit requirement, which requires health insurers to cover 10 specific categories of medical care. This includes things like mental health services and maternity coverage.
- Ending the Obamacare requirement that insurers charge sick and healthy people the same prices. This is called “community coverage,” and the Freedom Caucus would like to get rid of it, instead letting insurers charge higher premiums to sicker patients who they expect to cost more.
This is dangerous time folks and the media and consumers had better wake up to the reality of the dangers of the insurance industry and far right politicians. Continue reading
KEY TAKEAWAY: Via the WSJ: Patients who were encouraged by health coaches to review options and get more involved in choices had 5.3% lower overall medical costs, 12.5% fewer hospital admissions and fewer elective surgeries. Continue reading
Barry Werth, who has written two fine books about the biotech company Vertex,and says the the reason pharma raises prices is simple: “Because they can.”. Continue reading
LA TIMES: The Food and Drug Administration frequently speeds experimental medicines to sale by approving them before scientific evidence shows they work. For a drug called Tarceva, the FDA’s decisions resulted in thousands of lung cancer patients taking a drug that could not help them. Twelve years passed before the agency warned doctors in October that Tarceva only worked for a small number of patients with a rare gene mutation. Continue reading
KEY TAKEAWAY: Investment in DTC promotion shows no signs of slowing; pharma has been steadily increasing expenditure since 2012, and data for the period October 2015 to September 2016 show a rise of 18% on the previous year With the total for this period reaching $6bn, 2016 looks likely to have been a record year. Continue reading
KEY TAKEAWAY: Rethinking pharma productivity, an article by McKinsey consulting, is full of corporate consulting gibberish and is proof that they really don’t understand the business of our industry is helping people and helping employees help patients. Continue reading